Biotech | January 20, 2026
IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
Improvements were also seen in complete response rates, duration of response, and time to next treatment
Over 8.8?million Indians aged 60 and above currently live with dementia,
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Subscribe To Our Newsletter & Stay Updated
